Assessment of serum inflammatory parameters in RRMS and SPMS patients.

Maria Magdalena NowakNatalia NiedzielaZenon P CzubaPaweł SowaKrzysztof WierzbickiMichał LubczyńskiMonika Adamczyk-Sowa

Published in: Neurological research (2024)

Significant differences were found in BAFF, gp130, MMP-2 and osteopontin levels between RRMS and SPMS patients. Serum IL-32 levels were statistically lower in RRMS patients treated with disease-modifying therapy than in treatment-naïve patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
oxidative stress
bone marrow
patient reported